Ciprofloxacin Monohydrochloride is a fluoroquinolone antibiotic with high antibacterial activity.
Product Name Ciprofloxacin hydrochloride
Synonyms Ciprofloxacin base HCL CAS 86483-48-9
CAS: Ciprofloxacin hydrochloride 86483-48-9
MF: -
MW: -
EINECS: -
Product Categories: Agrochemical Intermediates;Intermediates & Fine Chemicals;Dyestuff Intermediates;Flavor & Fragrance Intermediates;Gatiflo, Tequin and Zymar;Pharmaceutical intermediates
Moxifloxacin is a fourth-generation synthetic fluoroquinolone antibacterial agent developed by Bayer AG (initially called BAY 12-8039). It is marketed worldwide (as the hydrochloride) under the brand names Avelox, Avalox, and Avelon for oral treatment. In most countries, the drug is also available in parenteral form for intravenous infusion. Moxifloxacin is also sold in an ophthalmic solution (eye drops) under the brand names Vigamox, and Moxeza for the treatment of conjunctivitis (pink eye). Its antibacterial spectrum includes enteric Gram-() rods (Escherichia coli, Proteus species, Klebsiella species), Haemophilus influenzae, atypical bacteria (Mycoplasma, Chlamydia, Legionella), and Streptococcus pneumoniae, and anaerobic bacteria. It differs from earlier antibacterials of the fluoroquinolone class such as levofloxacin and ciprofloxacin in having greater activity against Gram-positive bacteria and anaerobes. Because of its potent activity against the common respiratory pathogen Streptococcus pneumoniae, it is considered a "respiratory quinolone
Ciprofloxacin Monohydrochloride, an organic compound with chemical formula C17H19ClFN3O3, is a quinolone antimicrobial agent mainly used for urogenital infections caused by sensitive bacteria, including simple and complex urinary tract infections, bacterial prositis, Neisseria gonorrhoeae urethritis or cervicitis (including those caused by enzyme producing strains); Respiratory tract infections, including acute episodes of bronchial infections and pulmonary infections caused by sensitive gram-negative bacilli; Gastrointestinal tract infection, caused by Shigella, Salmonella, enterotoxin-producing Escherichia coli, Aeromonas hydrophila, Vibrio parahaemolyticus, etc. It can also treat typhoid bone and joint infection, skin and soft tissue infection, septicemia and other systemic infection
![Factory Supply Ciprofloxacin Monohydrochloride Powder CAS-93107-08-5](//www.micstatic.com/athena/img/transparent.png)
![Factory Supply Ciprofloxacin Monohydrochloride Powder CAS-93107-08-5](//www.micstatic.com/athena/img/transparent.png)
![Factory Supply Ciprofloxacin Monohydrochloride Powder CAS-93107-08-5](//www.micstatic.com/athena/img/transparent.png)
![Factory Supply Ciprofloxacin Monohydrochloride Powder CAS-93107-08-5](//www.micstatic.com/athena/img/transparent.png)
![Factory Supply Ciprofloxacin Monohydrochloride Powder CAS-93107-08-5](//www.micstatic.com/athena/img/transparent.png)
Q1. What's the MOQ?
A: MOQ is the minimum sales quantity of the product. Because each product has different prices and different packaging methods, there will be differences. Please consult the relevant professional sales manager for details.
Q2. What's the shipping time?
A: Usually the products we sell have enough stock to deliver the goods in a short
Q3.What transportation methods does our company have?
A: Our company cooperates with DHL and FedEx, as well as airlines and shipping companies. There are also some more efficient transportation methods, such as dedicated transportation lines.
Q4. Can you supply the free sample?
A: Generally, we will provide samples for customer testing to ensure that the quality of our products meets customer requirements.
Q5.Does our company support third-party testing?
A: Our company has long-term cooperation with well-known third-party testing agencies and can provide third-party testing services.